PanCanAID - Pancreas Cancer Artificial Intelligence Driven Diagnosis in CT Scan Imaging: A Protocol for a Multicentric Ambispective Diagnostic Study
Safavi-Naini, S. A. A.; Behnamnia, A.; Khorasanizadeh, F.; Soroush, A.; Zamani, F.; Salahshour, F.; Sadeghi, A.; Mirtajaddini, S.; Zandi, A.; Shojaeian, F.; Saeedi, M.; Ehasni, A.; Chavoshi Khamneh, A.; Mohsenifar, Z.; Azmoudeh Ardalan, F.; Firouznia, K.; Shahrokh, S.; Raoufi, M.; Dehghan, P.; Ketabi Moghadam, P.; Mansour-Ghanaei, A.; Mellatdoust, P.; Malekpour, H.; Rasekhi, A.; Mansour-Ghanaei, F.; Sohrabi, M.; Zarei, F.; Radmard, A. R.; Ghanaati, H.; Asadzadeh Aghdaei, H.; Zali, M. R.; Rabiee, H. R.
Show abstract
IntroductionPancreatic cancer is thought to have an extremely dismal prognosis. Most cancer-related deaths occur from metastasis rather than the primary tumor, although individuals with tumors smaller than 1 cm in diameter have more than 80% 5-year survival. Thus, the current protocol introduces PanCanAID project which intends to develop several computer-aided-diagnosis (CAD) systems to enhance pancreatic cancer diagnosis and management using CT scan imaging. Methods and analysisPatients with pathologically confirmed pancreatic ductal adenocarcinoma (PDAC) or pancreatic neuroendocrine tumor (PNET) will be included as pancreatic cancer cases. The controls will be patients without CT evidence of abdominal malignancy. A data bank of contrast-enhanced abdominopelvic CT scans, survival data, and demographics will be collected from ten medical centers in four provinces. Endosonography images and clinical data, if available, will be added to the data bank. Annotation and manual segmentation will be handled by radiologists and confirmed by a second expert radiologist in abdominal imaging. PanCanAID intelligent system is designed to (1) detect abdominopelvic CT scan phase, (2) segment pancreas organ, (3) diagnose pancreatic cancer and its subtype in arterial phase CT scan, (4) diagnose pancreatic cancer and its subtype in non-contrast CT scan, (5) carry out prognosis (TNM stage and survival) based on arterial phase CT scan, (6) and estimate tumor resectability. A domain adaptation step will be handled to use online data and provide pancreas organ segmentation to reduce the segmentation time. After data collection, a state-of-the-art deep learning algorithm will be developed for each task and benchmarked against rival models. ConclusionPanCanAID is a large-scale, multidisciplinary AI project to assist clinicians in diagnosing and managing pancreas cancer. Here, we present the PanCanAID protocol to assure the quality and replicability of our models. In our experience, the effort to prepare a detailed protocol facilitates a positive interdisciplinary culture and the preemptive identification of errors before they occur.
Matching journals
The top 6 journals account for 50% of the predicted probability mass.
Similar papers in this journal
Similar papers in this journal
- Segmentation of Pancreatic Ductal Adenocarcinoma (PDAC) and surrounding vessels in CT images using deep convolutional neural networks and Texture Descriptors 97%
- VISTA: Virtual ImmunoSTAining for pancreatic disease quantification in murine cohorts 95%
- On evaluation metrics for medical applications of artificial intelligence 95%
Similar papers in this journal
- Assessing GPT-4 Multimodal Performance in Radiological Image Analysis 95%
- A deep learning algorithm using CT images to screen for Corona Virus Disease (COVID-19) 93%
- From Community Acquired Pneumonia to COVID-19: A Deep Learning Based Method for Quantitative Analysis of COVID-19 on thick-section CT Scans 93%
Similar papers in this journal
- Demarcation line determination for diagnosis of gastric cancer disease range using unsupervised machine learning in magnifying narrow-band imaging 95%
- Auto-detection of motion artifacts on CT pulmonary angiograms with a physician-trained AI algorithm 94%
- Deep learning models for poorly differentiated colorectal adenocarcinoma classification in whole slide images using transfer learning 93%
Similar papers in this journal
- Inference of core needle biopsy whole slide images requiring definitive therapy for prostate cancer 94%
- Radiomic-Based Approaches in the Multi-metastatic Setting: A Quantitative Review 93%
- PDAC-ANN: an artificial neural network to predict Pancreatic Ductal Adenocarcinoma based on gene expression 92%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.